Cite
SGLT2 Inhibitors: A Game-Changer for Patients with Atrial Fibrillation?
MLA
Oraii, Alireza, et al. “SGLT2 Inhibitors: A Game-Changer for Patients with Atrial Fibrillation?” Journal of Atrial Fibrillation & Electrophysiology, vol. 15, no. 6, Nov. 2022, pp. 52–53. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=164071533&authtype=sso&custid=ns315887.
APA
Oraii, A., Healey, J. S., Pandey, A. K., & McIntyre, W. F. (2022). SGLT2 Inhibitors: A Game-Changer for Patients with Atrial Fibrillation? Journal of Atrial Fibrillation & Electrophysiology, 15(6), 52–53.
Chicago
Oraii, Alireza, Jeff S. Healey, Arjun K. Pandey, and William F. McIntyre. 2022. “SGLT2 Inhibitors: A Game-Changer for Patients with Atrial Fibrillation?” Journal of Atrial Fibrillation & Electrophysiology 15 (6): 52–53. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=164071533&authtype=sso&custid=ns315887.